Cutting-edge investment ideas in the Biotechnology and Pharmaceutical Industry.  REGISTER NOW to receive $10 worth of FREE credit.  This offer is valid for limited time only.
Cart

ACCURACY OF OPINIONS
80% - Correct
20% - Incorrect
 

RECENT NEWS ON COVERED STOCKS  

ISPH
click here

ACOR
click here

BSTC
click here

DDSS
click here

OPTR
click here

New BioMedicine
Event-based Healthcare Investment Reports
Historical Event Reports
Listed below are reports of historical events . You can use the advance search option to narrow down your search.
1-5 of 1041
Sort by Company Name | Date | Market Cap | Estimated Peak Sales
Idenix Pharmaceuticals, Inc. (IDIX) - IDX184 for Hepatitis C Virus (HCV) Infection (Phase II)

Phase II trial data of IDX184 for the treatment of hepatitis C virus (HCV) infection

Idenix Pharmaceuticals, Inc. ( IDIX ) - HISTORICAL EVENT(,3,2010) - December 22, 2009 - PDF - Price: $10.00 - Add to Cart »

Inspire Pharmaceuticals, Inc. (ISPH) - Prolacria for Dry Eye Syndrome (Phase III-Trial 03-113)

Top line data from the Phase III (Trial 03-113) trial of Prolacria designed for the treatment of dry eye syndrom

Inspire Pharmaceuticals, Inc. ( ISPH ) - HISTORICAL EVENT(,2,2010) - November 24, 2009 - PDF - Price: $10.00 - Add to Cart »

Achillion Pharmaceuticals, Inc. (ACHN) - ACH-1625 for Hepatitis C Vrus (HCV) Infection (Phase II)

Phase I/II trial data of ACH-1625, designed for the treatment of hepatitis C virus (HCV) infection

Achillion Pharmaceuticals, Inc. ( ACHN ) - HISTORICAL EVENT(,2,2010) - November 19, 2009 - PDF - Price: $10.00 - Add to Cart »

Incyte Corporation (INCY) - INCB18424 for Myelofibrosis/MF (Phase II)

Phase II trial of INCB18424, for the treatment of myelofibrosis (MF) at the American Society of Hematology (ASH) meet

Incyte Corporation ( INCY ) - HISTORICAL EVENT(08,12,2009) - November 09, 2009 - PDF - Price: $10.00 - Add to Cart »

Immunogen Inc. (IMGN) - Trastuzumab-DM1 for Breast Cancer (Phase II)

Phase II trial data of Trastuzumab-DM1 (T-DM1) for the treatment of third-line HER2 positive metastatic (advance

Immunogen Inc. ( IMGN ) - HISTORICAL EVENT(,12,2009) - November 05, 2009 - PDF - Price: $10.00 - Add to Cart »
Prev
1  2  3  4  5  6  7  8  9  10 
Next
1-5 of 1041
More Information ©Copyright 2009 New Bio Medicine, LLC. All Right Reserved. Privacy Policy